Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Phase I dose escalation of the Exportin 1 inhibitor, Selinexor, in combination with chemoradiation in patients with newly diagnosed glioblastoma.
Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026
Who Does What? Archetypes of Roles Assigned to LLMs During Human-AI Decision-Making.
Journal: ArXiv
Published: April 29, 2026
Temporal Integration of Serum Proteomics, Metabolomics and MRI Tumor Volumetrics via Deep Learning Identifies Systemic Mediators of Glioblastoma Response to Chemoradiotherapy.
Journal: Research square
Published: March 27, 2026
Drug Repurposing in Glioblastoma Using a Machine Learning-Based Hybrid Feature Selection Approach.
Journal: International journal of molecular sciences
Published: November 13, 2025
A Phase 1 Dose-Escalation Trial of Reirradiation for Patients With Recurrent Glioblastoma.
Journal: Practical radiation oncology
Published: September 19, 2025
Serum p-Cresol and 7-HOCA Levels and Fatty Acid and Purine Metabolism Are Associated with Survival, Progression, and Molecular Classification in GB-Serum Proteome and Metabolome Analysis Pre vs. Post Up-Front Chemoirradiation.
Journal: Current oncology (Toronto, Ont.)
Published: September 08, 2025
Radiomics and AI-Based Prediction of MGMT Methylation Status in Glioblastoma Using Multiparametric MRI: A Hybrid Feature Weighting Approach.
Journal: Diagnostics (Basel, Switzerland)
Published: March 24, 2025
GLIO-Select: Machine Learning-Based Feature Selection and Weighting of Tissue and Serum Proteomic and Metabolomic Data Uncovers Sex Differences in Glioblastoma.
Journal: International journal of molecular sciences
Published: February 24, 2025
Understanding the Immune System and Biospecimen-Based Response in Glioblastoma: A Practical Guide to Utilizing Signal Redundancy for Biomarker and Immune Signature Discovery.
Journal: Current oncology (Toronto, Ont.)
Published: November 13, 2024
Mucins as Precision Biomarkers in Glioma: Emerging Evidence for Their Potential in Biospecimen Analysis and Outcome Prediction.
Journal: Biomedicines
Published: November 05, 2024
MetaWise: Combined Feature Selection and Weighting Method to Link the Serum Metabolome to Treatment Response and Survival in Glioblastoma.
Journal: International journal of molecular sciences
Published: September 19, 2024
From manual clinical criteria to machine learning algorithms: Comparing outcome endpoints derived from diverse electronic health record data modalities.
Journal: PLOS digital health
Published: September 17, 2024
Last Updated: 09/26/2026